SITUATION Most clinical trial sponsors and CROs find it difficult to meet regulators’ requests for quantitative imaging data during clinical development. With limited in-house imaging capabilities and reliance on manual, subjective data-generation techniques, they often turn to third-party imaging vendors. However, few of these third-party firms have the combination of deep research knowledge, advanced technology, and creative problem- solving that are critical to meeting researchers’ needs for delivering scientifically valid imaging results. To adapt to this rapidly changing environment, ERT’s science-driven, purpose-built technology uses the latest imaging workflow management and image-analysis techniques to overcome the limitations of traditional, manual imaging approaches and

Join for free to read